Veeva Systems (NYSE: VEEV) today announced the acquisition of Ostro, the leading brand engagement platform for life sciences.
Ostro co-founder Ahmed Elsayyad explains how pharma marketers can earn attention by simplifying complexity, using engaging formats, and aligning content with audience needs in a crowded digital landscape.
Veeva is acquiring agentic AI company Ostro for $100 million to boost its AI capabilities for healthcare providers and patients.
AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.
The latest DHC Group Point of View tackles the practical implications head-on with exclusive new HCP research powered by Sermo and perspectives from Fullspan Health, Ostro, Perform Media, and HealthCentral.
Transform a generic brand.com into personalized experiences for a complex psychiatric treatment with Ostro Navigate.
How one oncology brand launched a complete patient support solution in two weeks.
.svg)